Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisAlessandro Cassini, Susan Hopkins|The Lancet Infectious Diseases|2018Cited by 3k
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in EnglandErik Volz, Neil M. Ferguson, Swapnil Mishra et al.|Nature|2021Cited by 1.3k
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic dataErik Volz, Neil M. Ferguson, Swapnil Mishra et al.|medRxiv|2021Cited by 654
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca Payne, Victoria Hall, Susan L. Dobson et al.|Cell|2021Cited by 352
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy Thwaites, Elian Liu, Matthew Scarborough et al.|The Lancet|2017Cited by 186